YEREVAN. – Uzbekistan’s medical drug market has prospects for Armenian drug manufacturers. This is noted in the Pharmacy and Biotechnologies program document, which is a part of Armenia’s industrial policy geared toward export.
In 2010, Armenia exported US$ 8 million-worth pharmaceutical products, and the annual export growth is close to 20 percent. By 2015, export is expected to reach up to $20-25 million, and by 2020, $75-115 million.
Armenian-made drugs are currently exported to these countries: Georgia (38%), Russia (18%), Uzbekistan (13%), Belarus (6%), Ukraine (5%), and Qatar (4%).
Uzbekistan’s market is considered to be full of prospect because of its low development level and large population.